← FDA DRUG APPROVALS

FDA ANDA · ANDA090480

MUPIROCIN

Sponsor: GLENMARK PHARMS

APPLICATION
ANDA090480
TYPE
ANDA
ORIGINAL APPROVAL
2011-06-08
LATEST ACTION
2021-08-04
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

MUPIROCINPrescription
MUPIROCIN 2% · OINTMENT · TOPICAL

Approval history

2021-08-04Labeling · Supplement 6 · standardAP
2021-08-04Labeling · Supplement 5 · standardAP
2016-01-05Labeling · Supplement 4 · standardAP
2016-01-05Labeling · Supplement 2 · standardAP
2011-06-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →